Menopausal status influences long-term benefit from anti-hormonal treatment, study shows
Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk tumors have a long-term benefit for at least 20 years, while the benefit was more ...
Dec 4, 2024
0
24









